Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.
Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears to reduce anxiety without side effects.
Hospices are increasingly owned by private equity firms and publicly traded companies, but recently Weill Cornell Medicine researchers found that they performed substantially worse than hospices owned by not-for-profit agencies.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
A new method developed at Cornell provides tools and methodologies to compress hundreds of terabytes of genomic data to gigabytes, once again enabling researchers to store datasets in local computers.
The newest episode of the Startup Cornell podcast features Jamey Edwards '96 MBA '03, president & chief strategy officer at Koko Home, a company providing radar driven, AI-enabled solutions for healthcare and an Entrepreneur in Residence of StartUp Health, which was founded in 2011 to invest in global health entrepreneurs.
Weill Cornell Medicine researchers found that the possibility of parental disclosure through online patient portals led older adolescents to hesitate in sharing complete health information with doctors.